CLINICAL EFFECTIVENESS OF MILDRONATE IN PATIENTS WITH CONNECTIVE TISSUE DYSPLASIA: EXPERIENCE OF THE SPECIALIZED CLINICAL CENTRE, OMSK CITY

CLINICAL EFFECTIVENESS OF MILDRONATE IN PATIENTS WITH CONNECTIVE TISSUE DYSPLASIA: EXPERIENCE OF THE SPECIALIZED CLINICAL CENTRE, OMSK CITY

.

Bibliographic Details
Main Authors:	G. I. Nechaeva, I. A. Viktorova, G. S. Dubiley, I. V. Druk, Yu. V. Tereshchenko, S. A. Kalinicheva
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2011-06-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1108

Similar Items

CLINICAL FEATURES AND CHARACTERISTICS OF VEGETATIVE STATUS IN CHILDREN AND ADOLESCENTS WITH CONNECTIVE TISSUE DYSPLASIA
by: I.A. Viktorova, et al.
Published: (2008-10-01)

CLINICAL FEATURES AND CHARACTERISTICS OF VEGETATIVE STATUS IN CHILDREN AND ADOLESCENTS WITH CONNECTIVE TISSUE DYSPLASIA
by: I.A. Viktorova, et al.
Published: (2008-01-01)

PATHOLOGY OF THORACIC AORTA IN CONNECTIVE TISSUE DYSPLASIAS
by: G. I. Nechaeva, et al.
Published: (2018-03-01)

CLINICAL EFFECTIVENESS AND ANTIOXIDANT ACTIVITY OF MILDRONATE IN ISCHEMIC STROKE
by: M. Yu. Maksimova, et al.
Published: (2009-08-01)

ANTIOXIDANT EFFECT OF MILDRONATE IN PATIENTS AFTER CORONARY REVASCULARISATION
by: I. G. Gordeev, et al.
Published: (2009-02-01)

Clinical and epidemiological peculiarities of cervical precancer in female residents of Omsk
by: T V Klinyshkova, et al.
Published: (2013-06-01)

Experience with mildronate in cerebrovascular diseases
by: N. V. Pizova
Published: (2015-12-01)

The prevalence of traditional risk factors for cardiovascular disease in the Omsk region: data of the ESSE-RF2 study
by: I. A. Viktorova, et al.
Published: (2020-07-01)

Modernization of economy of Omsk Region: contribution of Omsk State Technical University
by: O. P. Kuznetsova, et al.
Published: (2018-10-01)

MILDRONATE POTENTIAL IN PATIENTS WITH CARDIOVASCULAR DISEASE
by: V. P. Mikhin, et al.
Published: (2010-08-01)

Opportunities of ivabradine to reduce heart rate before CT coronary angiography in young patients with connective tissue dysplasia
by: I. V Druk, et al.
Published: (2014-03-01)

Mildronate effects on cognitive function in elderly patients with arterial hypertension
by: S. V. Nedogoda, et al.
Published: (2012-10-01)

ADRENORECEPTOR SENSITIVITY AND MAGNESIUM THERAPY IN PATIENTS WITH CARDIAC ARRHYTHMIAS AND CONNECTIVE TISSUE DYSPLASIA
by: G. I. Nechaeva, et al.
Published: (2012-08-01)

MILDRONATE POTENTIAL FOR CORRECTING COGNITIVE DYSFUNCTION IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION
by: M. E. Statsenko, et al.
Published: (2011-08-01)

The Incidence and Clinical Characteristics of the Connective Tissue Dysplasia in Adolescents
by: Ganna Y. Kalaeva, et al.
Published: (2017-12-01)

TRIMETAZIDINE AND MILDRONATE AS DIRECT ACTION Β2 - ADRENOSENSIBILIZERS (EXPERIMENTAL EVIDENCE)
by: V. I. Tsirkin, et al.
Published: (2002-02-01)

90 years anniversary of the Pathophysiology Chair with the Clinical Pathophysiology Course of the Omsk State Medical Academy
by: V. T. Dolgikh, et al.
Published: (2012-02-01)

CLINICAL AND IMMUNOHISTOCHEMICAL STUDIES IN THE DIAGNOSIS OF UNDIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA IN PATIENTS WITH CHOLELITHIASIS
by: S. E. Gumenyuk, et al.
Published: (2016-12-01)

Development and clinical course of diseases accompanied by connective tissue dysplasia in children of puberty age
by: Elizarova S.Yu., et al.
Published: (2011-03-01)

MILDRONATE POTENTIAL FOR CARDIAC ARRHYTHMIA PREVENTION IN PERIOPERATIVE PERIODcardiac arrhythmias, ischemia, metabolic disturbances, cytoprotectors, antioxidants, operation-related stress, general anesthesia, Mildronate
by: V. P. Mikhin, et al.
Published: (2014-02-01)

CYTOPROTECTOR MILDRONATE IN CORRECTING MYOCARDIAL DYSFUNCTION AMONG STABLE ANGINA PATIENTS AFTER CORONARY REVASCULARISATION
by: I. G. Gordeev, et al.
Published: (2009-04-01)

Eating habits among the Omsk Oblast population and poor nutrition in association with cardiovascular diseases according to the ESSE-RF2 study
by: I. A. Viktorova, et al.
Published: (2021-06-01)

OMSK SCHOOL OF PEDIATRICIANS
by: N.V. Sobotyuk, et al.
Published: (2008-01-01)

OMSK SCHOOL OF PEDIATRICIANS
by: N.V. Sobotyuk, et al.
Published: (2008-01-01)

THE CHANGES IN THE STRUCTURE OF LOCALIZATIONS, PREVALENCE AND CLINICAL FORMS OF TUBERCULOSIS IN CHILDREN FROM 1985 TO 2015 IN OMSK REGION
by: N. I. PORKULEVICH, et al.
Published: (2017-10-01)

Mildronate efficacy and tolerance in chronic heart failure patients therapy
by: A. S. Galiavich, et al.
Published: (2005-10-01)

"TREAT THE PATIENT, RATHER THAN THE DISEASE": MILDRONATE AS A COMPONENT OF COMPLEX CARDIOVASCULAR THERAPY
by: I. G. Gordeev, et al.
Published: (2013-06-01)

Clinical and Functional Features of Acute Bronchitis in Infants on Connective Tissue Dysplasia
by: E. E. Krasnova, et al.
Published: (2013-03-01)

The effect of mildronate on the circadion biorhythm of the parametrs of the excretory renal function
by: R B Kosuba, et al.
Published: (2012-12-01)

Mildronate effectiveness in post-hospital rehabilitation of patients with myocardial infarction
by: V. P. Mikhin, et al.
Published: (2012-04-01)

Factor analysis in maternal mortality study in Omsk region in 1995-2003
by: G. V. Fyodorova, et al.
Published: (2006-03-01)

Clinical and biochemical manifestations of undifferentiated forms of connective tissue dysplasia in pregnant women with varicose veins of small pelvis
by: N.M. Shibelgut, et al.
Published: (2010-03-01)

MILDRONATE EFFECT ON ENDOTHELIUM-DEPENDENT VASODILATION IN PATIENTS WITH CHRONIC HEART FAILURE: DOUBLE BLIND CROSSOVER STUDY
by: L. G. Voronkov, et al.
Published: (2016-01-01)

Epidemiology of Omsk Haemorragic Fever
by: N. V. Rudakov, et al.
Published: (2015-02-01)

Influence of cardioprotectors mildronate and trimetazidine on MB-creatinkinase activity in stable angina patients after coronary bypass surgery
by: I. G. Gordeev, et al.
Published: (2004-12-01)

Central hemodynamics changes in patients with coronary heart disease, stable effort angina, treated with mildronate
by: M. V. Baluda, et al.
Published: (2007-08-01)

New views of mildronate use for the prevention and correction of impairment of adaptive processes
by: L V Logunova
Published: (2010-06-01)

New views of mildronate use for the prevention and correction of impairment of adaptive processes
by: L V Logunova
Published: (2009-03-01)

THE ASSESSMENT OF EFFECTS OF COMBINED THERAPY WITH MILDRONATE ON LIPID PROFILE, INFLAMMATORY FACTORS AND ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: I. V. Sergienko, et al.
Published: (2015-12-01)

THE ASSESSMENT OF EFFECTS OF COMBINED THERAPY WITH MILDRONATE ON LIPID PROFILE, INFLAMMATORY FACTORS AND ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: I. V. Sergienko, et al.
Published: (2015-12-01)